ArticleThoracic cancer2022

Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer.

Miwako Omori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.